|
Disease-Free Survival
|
N05.715.360.750.795.300 |
|
|
Survival Analysis
|
N05.715.360.750.795 |
|
|
Polycomb Repressive Complex 1
|
D12.776.660.235.600.100 |
|
|
Mycoplasma penetrans
|
B03.440.860.580.553.553.645 |
|
|
Receptors, Oxytocin
|
D12.776.543.750.695.630 |
|
|
Hymenaea
|
B01.650.940.800.575.912.250.401.327 |
|
|
Antigens, CD1d
|
D23.050.301.264.035.100.500 |
|
|
Maternal Inheritance
|
G05.420.275.750 |
|
|
Hallucinogens
|
D27.505.696.388 |
|
|
Magnesium Silicates
|
D01.578.725.500 |
|
|
DiGeorge Syndrome
|
C19.642.482.500.500 |
|
|
22q11 Deletion Syndrome
|
C19.642.482.500 |
|
|
Baroreflex
|
G11.561.731.063 |
|
|
Berberine Alkaloids
|
D03.633.400.168 |
|
|
Parenteral Nutrition Solutions
|
D27.505.954.578.733 |
|
|
Ursodeoxycholic Acid
|
D04.210.500.221.430.342.925 |
|
|
Cystine Depleting Agents
|
D27.505.519.334 |
|
|
Mycoplasma orale
|
B03.440.860.580.553.553.630 |
|
|
Tooth Cervix
|
A14.549.167.900.700 |
|
|
Indigofera
|
B01.650.940.800.575.912.250.401.337 |
|
